Aileron Therapeutics
Latest round
- Series E
Last raised
- Oct 2014
Total raised
- $95M
Investors
- 7
About Aileron Therapeutics
Aileron Therapeutics, Inc.Founded in 2005 and headquartered in Watertown, US, Aileron Therapeutics, Inc. specializes in innovative therapies for cancer treatment.90 mn.Aileron Therapeutics is dedicated to the development of multi-pathway therapeutics aimed at treating cancer. The company's primary offering is a proprietary platform that enables the design of drugs targeting specific pathways in cancer biology, thereby aiming to improve therapeutic efficacy.16 mn. The company aims to expand into European markets by 2023, enhancing its reach and impact.
Who invested in Aileron Therapeutics
7 investors across 7 rounds
See all investors in Aileron Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series E
Oct 29, 2014
Amount
$20M
Investors
Series E
Nov 8, 2013
Amount
$15M
Investors
Series D
Jan 1, 2013
Amount
$15M
Investors
Series D
May 29, 2009
Amount
$28M
Investors
Series C
Apr 3, 2008
Amount
$0.3M
Investors
Series C
Nov 28, 2007
Amount
$10M
Investors
Series C
Jun 6, 2007
Amount
$7M
Investors
Questions about Aileron Therapeutics
Who invested in Aileron Therapeutics?
Aileron Therapeutics has 7 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aileron Therapeutics raised?
Aileron Therapeutics has raised 7 venture rounds. Sign up free to see how much each round raised and the total.
When did Aileron Therapeutics last raise money?
Aileron Therapeutics's most recent round on record is a Series E, in Oct 2014.
What does Aileron Therapeutics do?
Aileron Therapeutics is a biotechnology company.
Where is Aileron Therapeutics headquartered?
Aileron Therapeutics is headquartered in Watertown, US.
Which VCs invest in companies like Aileron Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Aileron Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like Aileron Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.